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The balance between growth stimulatory and growth
inhibitory signals is essential for normal tissue homeosta-
sis. An imbalance of these signals may favour the devel-
opment of uncontrolled proliferation, leading to
neoplasia. Transforming growth factor (TGF)-b plays an
important role in the regulation of mammary duct devel-
opment and cellular proliferation in the mammary gland
during adult life. The different in vitro and in vivo models
that have shed light on mammary development and the
limitations of these models are presented in the first
review of this series. The second article reviews murine
models that have provided insights, not only into the role
of TGF-b in mammary development, but also into its role
in tumour suppression. TGF-b receptors and the Smad
signalling molecules transduce TGF-b signals. The study
of these has yielded important insights into the regula-
tion of this pathway. A review of the many levels at which
TGF-b signalling can be disrupted during oncogenesis is
presented in this series. TGF-b is a potent mediator of
G1 arrest in mammary epithelial and other cell types.
Mechanisms of G1 arrest by TGF-b and their dysregula-
tion in cancers are addressed. In a final review, the tumor
promoting effects of TGF-b are discussed. In advanced
stages of breast cancer, not only is the cell cycle arrest
response to TGF-b lost, but, in addition, this pathway
can be subverted in such a way that TGF-b signalling
indirectly supports tumour viability, invasiveness and
malignant progression.
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